Management Paradigms for Chronic Rhinosinusitis in Individuals with Asthma: An Evidence ‐Based Review with Recommendations

Conclusion: Evidence supports managing CRS in individuals with CRSwA in a stepwise fashion, starting with traditional non-biologic oral and topical medication, and escalating to second-line treatments, such as ESS and biologics. Optimal treatment of individuals who suffer from CRSwA often requires concurrent, directed management of asthma, as not all CRS interventions impact asthma status.This article is protected by copyright. All rights reserved

Source: International Forum of Allergy and Rhinology - December 30, 2022 Category: Allergy & Immunology Authors: Amarbir S. Gill, Jeremiah A. Alt, Kara Y. Detwiller, Nicholas R. Rowan, Stacey T. Gray, Peter W. Hellings, Shyam R. Joshi, Jivianne T. Lee, Zach M. Soler, Bruce K. Tan, Jennifer L. Taylor ‐Cousar, Sarah K. Wise, Tara J. Wu, Daniel M. Beswic Tags: REVIEW ARTICLE Source Type: research